m7-FLIPI identifies patients with early disease progression of FL after therapy
Overview of RESONATE-2 clinical trial of ibrutinib in CLL
John Gribben et al.
Biomarkers of cardiotoxicity in multiple myeloma
How far are we from a cure for CLL?
Identification of high-risk disease using Molecular profiling by Mymap